OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models

Summary

Thirty-two healthy volunteers will be submitted to experimental pain and on the 2 study days receive Oxycodone 20 mg po vs. placebo. Half of the volunteers will be poor metabolizers according to CYP2D6 genotype and half will be extensive metabolizers (EM) and have an enzyme with normal function. The study hypothesis is that PM will experience less pain relief than EM.

Timeline

Start

2006-02

Primary completion

—

Completion

2007-01

Drugs

Indications

No indication recorded.